ArticleClinical cancer research : an official journal of the American Association for Cancer Research2001

Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kappa B, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma.

J B Sunwoo et al.PubMed ↗

No numbers read from the abstract.